Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
71 participants
OBSERVATIONAL
2016-12-01
2018-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
By comparing postnatal growth in ELBW infants hospitalized in two European neonatal intensive care units with different nutritional and extra nutritional care,our objective was to evaluate the role of nutrition in this population of preterm infants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Initial Nutritional Strategy and Stature-level Growth During the Neonatal Period of Children Born Moderately Premature
NCT03662503
Nutrition Protocol and Premature Infants' Growth
NCT03217045
Outcomes Following Early Parenteral Nutrition Use in Preterm Neonates
NCT03767634
Acquisition of Full Oral Feeding and Further Oral Disorders in Extremely Preterm Infants
NCT06648083
Growth, Health and Development in Children Born Extremely Preterm
NCT01150071
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Body weight, crown-heel length and head circumference were measured in both units at birth and until discharge. We calculated z-scores and changes in z-scores between birth and 36 weeks post-conceptional age (delta z-score) for body weight, HC, and crown-to-heel length using Olsen's references. Intra-uterine growth restriction was defined as a birth weight below or equal to minus two standard deviations. Extra-uterine growth restriction was defined as a z-score loss above or equal one standard deviation between birth and 36 weeks PCA. I
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Infants born in Lyon (France)
No interventions assigned to this group
Group B
Infants born in Stockholm (Sweden)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* gestational age (GA) between 23 and 28 weeks
* born in 2012
* admitted during the first 24 hours of life
* stayed in one of the two studied units for at least 7 weeks before transfer to the referring hospital, discharge to home or death.
Exclusion Criteria
1 Minute
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital de la Croix-Rousse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean-charles PICAUD, MD, PhD
professor of pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jean-charles picaud, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hopital de la croix rousse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital de la croix rousse
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PICAUD JC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.